|
CBX4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.49890166523915E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.00449681695159E-11 |
| Normal-vs-Stage2 |
1.88280000035235E-07 |
| Normal-vs-Stage3 |
2.12689999999904E-05 |
| Normal-vs-Stage4 |
5.85949999999391E-05 |
| Stage1-vs-Stage2 |
4.846200E-01 |
| Stage1-vs-Stage3 |
2.441600E-02 |
| Stage1-vs-Stage4 |
4.106200E-01 |
| Stage2-vs-Stage3 |
2.336100E-02 |
| Stage2-vs-Stage4 |
1.928030E-01 |
| Stage3-vs-Stage4 |
4.567600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.91689952378749E-10 |
| Normal-vs-AfricanAmerican |
7.524800E-03 |
| Normal-vs-Asian |
1.45839999998731E-06 |
| Caucasian-vs-AfricanAmerican |
9.861800E-01 |
| Caucasian-vs-Asian |
5.709800E-01 |
| AfricanAmerican-vs-Asian |
7.094200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62629999467256E-08 |
| Normal-vs-Female |
2.52210030637912E-10 |
| Male-vs-Female |
9.768800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.30570007531128E-10 |
| Normal-vs-Age(41-60Yrs) |
1.91740000543561E-08 |
| Normal-vs-Age(61-80Yrs) |
4.75310000025431E-07 |
| Normal-vs-Age(81-100Yrs) |
2.276600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.953800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.747000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.482800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.204200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.392400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.982200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.20970000683229E-09 |
| Classical-VS-Follicular |
7.336000E-03 |
| Classical-VS-Other |
9.178000E-01 |
| Classical-VS-Normal |
2.67539990161936E-10 |
| Tall-VS-Follicular |
1.79879999784305E-09 |
| Tall-VS-Other |
3.503200E-03 |
| Tall-VS-Normal |
5.130000E-01 |
| Follicular-VS-Other |
1.246950E-01 |
| Follicular-VS-Normal |
4.32179958487211E-10 |
| Other-VS-Normal |
8.398400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.15599751993045E-11 |
| Normal-vs-N1 |
4.29370000000207E-05 |
| N0-vs-N1 |
2.847500E-02 |
|
|
